Basit öğe kaydını göster

dc.contributor.authorGümüş, Aziz
dc.contributor.authorÖner, Veysi
dc.date.accessioned2020-12-19T19:58:22Z
dc.date.available2020-12-19T19:58:22Z
dc.date.issued2015
dc.identifier.citationGümüş, A., & Öner, V. (2015). Follow up of retinal nerve fiber layer thickness with optic coherence tomography in patients receiving anti-tubercular treatment may reveal early optic neuropathy. Cutaneous and ocular toxicology, 34(3), 212–216. https://doi.org/10.3109/15569527.2014.954715en_US
dc.identifier.issn1556-9527
dc.identifier.issn1556-9535
dc.identifier.urihttps://doi.org/10.3109/15569527.2014.954715
dc.identifier.urihttps://hdl.handle.net/11436/2955
dc.descriptionWOS: 000361329600007en_US
dc.descriptionPubMed: 25363070en_US
dc.description.abstractPurpose: To evaluate the effect of anti-tubercular treatment on retinal nerve fiber layer (RNFL) thickness and the efficiency of optic coherence tomography (OCT) on early diagnosis of optic neuropathy. Methods: Twenty patients diagnosed with either pulmonary or extra-pulmonary tuberculosis which were treated with anti-tubercular treatment (isoniazid (INH), rifampicin, ethambutol (ETM), and pyrazinamide) were enrolled in the study. RNFL thicknesses of the patients were measured via OCT, at baseline (before starting anti-tubercular treatment) and after the two-month treatment period. Standard ophthalmologic examinations were also performed. Results: Compared to baseline values, after the two-month treatment period, thinning was detected in the right eye's average and superior quadrant RNFLs (p = 0.024 and p = 0.006 respectively) and in the left eye's average, superior quadrant, and inferior quadrant RNFLs (p = 0.001, p = 0.008, p<0.001, respectively). Conclusion: We displayed that patients receiving INH and ETM, which were the basic medicines of anti-tubercular treatment, experienced thinning in RNFL after the two-month treatment period. Patients receiving these drugs can be followed via OCT in terms of reduction in RNFL thicknesses for early diagnose of INH and ETM toxicity.en_US
dc.language.isoengen_US
dc.publisherTaylor & Francis Ltden_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectEthambutolen_US
dc.subjectIsoniaziden_US
dc.subjectOptic coherence tomographyen_US
dc.subjectRetinal nerve fiber layer thicknessen_US
dc.titleFollow up of retinal nerve fiber layer thickness with optic coherence tomography in patients receiving anti-tubercular treatment may reveal early optic neuropathyen_US
dc.typearticleen_US
dc.contributor.departmentRTEÜ, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümüen_US
dc.contributor.institutionauthorGümüş, Aziz
dc.contributor.institutionauthorÖner, Veysi
dc.identifier.doi10.3109/15569527.2014.954715
dc.identifier.volume34en_US
dc.identifier.issue3en_US
dc.identifier.startpage212en_US
dc.identifier.endpage216en_US
dc.relation.journalCutaneous and Ocular Toxicologyen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US


Bu öğenin dosyaları:

Thumbnail

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster